Kleiner Device Labs Completes First 50 Surgical Cases With KG2 Surge Flow-Thru Interbody System

Kleiner Device Labs today announced that its new KG®2 Surge®flow-thru interbody system was recently used in its 50th surgical case.

Noted founder and CEO Jeff Kleiner, MD, “The new KG2 Surge was developed with the objectives of maximizing bone graft delivery to the prepared intervertebral disc space, and streamlining implant placement, positioning, and integration in the graft matrix.  The first fifty cases demonstrated excellent achievement of those objectives.  We will next be moving to broader commercial availability, expanding our network of distributors and independent representatives.”

“Overall, I think surgeons have lost track of the importance of meticulous disc space preparation and abundant, quality bone graft delivery and packing into the disc space well enough to achieve high fusion rates,” said surgeon Jeffrey Dick, MD, of Twin Cities Orthopedics.  “One of the best things about the KG2 is the ease with which one can deliver abundant bone graft through the tube and how tightly you can pack it compared to conventional techniques.”

Neurosurgeon Catherine Gallo, MD of Two Rivers Surgical Center in Eugene, Oregon, said, “I can tell that the KG2 is a very well-thought-out cage design.  Somebody put some real thought into this.  It is very user-friendly.”

Orthopedic spine surgeon Blake Burkert, MD, of NeuroSpine in Eugene, Oregon, commented, “I will change my approach and do more PLIFs because the KG2 system is so easy to use and the graft volume is impressive.  Love this cage system.”

The KG2 Surge flow-thru interbody system is a single-patient-use bone graft delivery tool coupled with a 3D-printed titanium I-Beam fusion implant. The implant has no lateral walls and serves as a conduit for unimpeded flow of a broad spectrum of bone graft materials through the pre-attached, rectangular insertion tool. The rectangular cannula maximizes the cross-sectional area available for graft material flow and eliminates the challenge of trying to apply bone graft after cage insertion. Since the system comes pre-assembled and sterilized in a single use tray, there is minimal scrub tech training and no implant tray re-processing/sterilization — an ideal system for an ASC or hospital. The KG2 system allows for a single insertion process to take the place of the multi-step, multi-instrument pass practice. The surgical procedure with KG2 Surge spares contusion of delicate nerve tissue and reduces the risk of surgical site infection.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version